Resultado de búsqueda
The U.S. Preventive Services Task Force (USPSTF) is an independent panel of experts that makes recommendations about clinical preventive services. Find out about their latest draft and final recommendations, public comments, news, and tools for primary care clinicians.
- Recommendations
Recommendation Topics. The U.S. Preventive Services Task...
- Public Comments & Nominations
The USPSTF email list is open to all organizations and...
- News
The following is information about the U.S. Preventive...
- About the USPSTF
About the USPSTF The U.S. Preventive Services Task Force...
- Opportunity for Public Comment
The USPSTF posts its draft Recommendation Statement on this...
- Our Partners
Partner organization representatives contribute their...
- Conflict of Interest Disclosures
All disclosures are reviewed by the Task Force Chairs...
- Contact Us
You can use this form to contact the U.S. Preventive...
- Recommendations
The USPSTF provides evidence-based recommendations for preventive services that are relevant for implementing the Affordable Care Act. See the list of A and B grade recommendations for various topics, such as screening, medication, and interventions.
The Task Force is an independent panel of experts that reviews the evidence and develops recommendations for clinical preventive services. Find the latest final recommendations, discussion guides, quizzes, and tools for patients and clinicians on various topics.
The USPSTF is an independent group of experts that makes evidence-based recommendations about preventive services. AHRQ provides support to the USPSTF, such as operations, evidence reports, and dissemination.
USPSTF is an independent group of experts that makes evidence-based recommendations about preventive services. AHRQ provides administrative, research, technical, and communication support to the Task Force.
Explore Recommendation Statements and accompanying evidence reports about cancer screening and prevention and more from the USPSTF.
Relative to the 2013 USPSTF recommendation (A-55-80-30-15), the 2021 USPSTF recommendation (A-50-80-20-15) would be associated with an estimated 38.6 vs 20.6 radiation-related lung cancer deaths per 100 000 persons in the total population aged 45 to 90 years, or 1 death caused for every 13.0 vs 18.5 lung cancer deaths avoided by screening. 14
